2005 Stock Overview
An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
SSY Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.95 |
| 52 Week High | HK$5.06 |
| 52 Week Low | HK$2.88 |
| Beta | 0.60 |
| 1 Month Change | -13.24% |
| 3 Month Change | -6.05% |
| 1 Year Change | -38.28% |
| 3 Year Change | -21.96% |
| 5 Year Change | -47.04% |
| Change since IPO | 13.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2005 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -2.0% | 1.2% | 1.5% |
| 1Y | -38.3% | 12.0% | 14.7% |
Return vs Industry: 2005 underperformed the Hong Kong Pharmaceuticals industry which returned 12% over the past year.
Return vs Market: 2005 underperformed the Hong Kong Market which returned 14.7% over the past year.
Price Volatility
| 2005 volatility | |
|---|---|
| 2005 Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 7.8% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in HK Market | 15.3% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 2005 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2005's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 6,146 | Jiguang Qu | www.ssygroup.com.hk |
SSY Group Limited, an investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials.
SSY Group Limited Fundamentals Summary
| 2005 fundamental statistics | |
|---|---|
| Market cap | HK$8.71b |
| Earnings (TTM) | HK$1.06b |
| Revenue (TTM) | HK$5.77b |
8.2x
P/E Ratio1.5x
P/S RatioIs 2005 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2005 income statement (TTM) | |
|---|---|
| Revenue | HK$5.77b |
| Cost of Revenue | HK$2.86b |
| Gross Profit | HK$2.91b |
| Other Expenses | HK$1.85b |
| Earnings | HK$1.06b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.36 |
| Gross Margin | 50.37% |
| Net Profit Margin | 18.38% |
| Debt/Equity Ratio | 48.2% |
How did 2005 perform over the long term?
See historical performance and comparisonDividends
5.9%
Current Dividend Yield49%
Payout RatioDoes 2005 pay a reliable dividends?
See 2005 dividend history and benchmarks| SSY Group dividend dates | |
|---|---|
| Ex Dividend Date | May 20 2025 |
| Dividend Pay Date | Jun 03 2025 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 28 days |
Does 2005 pay a reliable dividends?
See 2005 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/04 17:53 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SSY Group Limited is covered by 21 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Derrick Sun | BNP Paribas Securities (Asia) |
| Ying Shao | BofA Global Research |
| Yanyin Zhu | China International Capital Corporation Limited |